A new multiplex PCR-based reverse line-blot hybridization (mPCR/RLB) assay for rapid staphylococcal cassette chromosome mec (SCCmec) typing
INTRODUCTION
Morbidity and mortality from meticillin-resistant Staphylococcus aureus (MRSA) infections and the emerging threat of community-associated MRSA highlight the importance of timely surveillance (Aires de Sousa & de Lencastre, 2004; Ma et al., 2002) . Meticillin resistance is conferred by the mecA gene, which is carried on a mobile genetic element known as the staphylococcal cassette chromosome mec (SCCmec) (Ito & Hiramatsu, 1998; Ito et al., 1999) . The combination of mec complex class and cassette chromosome recombinase (ccr) genes determines the SCCmec type (Ito et al., 2004; Kondo et al., 2007) . Currently, seven SCCmec types (I-VII) and a number of subtypes have been described, ranging in size from 20.9 to 66.9 kb (Ito et al., 2001 (Ito et al., , 2004 Daum et al., 2002; Oliveira et al., 2006a; Takano et al., 2008) . SCCmec types I and IV-VII are usually resistant only to b-lactam antibiotics, while types II and III are often resistant to multiple classes of antibiotics due to additional resistance genes integrated into SCCmec (Deurenberg & Stobberingh, 2008) . MRSA SCCmec types I-III have been linked with healthcareassociated infections (Ito et al., 2001) whereas communityacquired MRSA infections are typically caused by SCCmec types IV, V or VII (Ito et al., 2004; Daum et al., 2002; Takano et al., 2008) . Evidence has been emerging of IP: 54.70.40.11 On: Sat, 29 Dec 2018 20:47:40 potential associations between MRSA genotype and clinical outcomes (Lalani et al., 2008) . SCCmec typing and subtyping provides an opportunity to detect and reduce the transmission of MRSA in healthcare settings (Ito et al., 2004; Kondo et al., 2007) . Several multiplex PCR (mPCR)-based methods have been described to determine the structure of the SCCmec complex (Oliveira & de Lencastre, 2002; Zhang et al., 2005; Kondo et al., 2007; Milheirico et al., 2007) but most require several reactions, produce long amplicons and are time consuming (Chongtrakool et al., 2006; Kondo et al., 2007) , making them impractical for outbreak investigations or early-warning systems. Identification of the 46 major and minor SCCmec variants currently known relies on detection of the presence or absence of at least 22 of 34 binary targets (Stephens et al., 2007) . mPCR-based reverse line-blot hybridization assay (mPCR/RLB) can overcome the limitations of current methods by allowing rapid and simultaneous detection of a large number of different PCR products using membrane-bound sequence-specific probes . This technique has been successfully applied to molecular typing of Streptococcus agalactiae (Kong et al., 2005) , Streptococcus pneumoniae and Staphylococcus aureus (Cai et al., 2007) .
The aim of this study was to develop a new discriminatory method for MRSA SCCmec typing based on mPCR/RLB suitable for the rapid identification and classification of the MRSA isolates in a clinical laboratory.
METHODS
Bacterial isolates. Seven well-characterized reference strains [Cai et al., 2007;  kindly provided by Professor Herminia de Lencastre, Instituto de Tecnologia Química e Bioló gica, Universidade Nova de Lisboa (UNL), Oeiras, Portugal] and 35 previously characterized clinical strains (provided by Drs Graeme Nimmo, Queensland Health Pathology Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia, and Philip Giffard, Cooperative Research Centre for Diagnostics, Queensland University of Technology, Brisbane, Queensland, Australia) were used in this study (Table 1) . Isolates were stored at -70 uC, until DNA extracts were prepared, as previously described (Cai et al., 2007) ; the latter were stored at -20 uC until tested. PC8d
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C801535d t325 ST88-SCCmec-new *spa type described by Cai et al. (2007) . DSTy, single nucleotide polymorphism (SNP) type as described previously using the computer program Minimum SNPs to compare with existing MLST data Stephens et al., 2006; Coombs et al., 2004) . §Seven isolates, which had been used in previous studies (Oliveira et al., 2006b) , were provided by Professor Herminia de Lencastre, Instituto de Tecnologia Química e Bioló gica, Universidade Nova de Lisboa, Oeiras, Portugal; spa types identified in this study were identical with those previously reported for these strains (Cai et al., 2007) . 
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Primer and probe design. The mPCR primers (Kondo et al., 2007) were modified to adjust T m values to 60-65 uC and labelled with biotin. Immediate downstream or upstream sequences of the published sense and antisense primers were used to design antisense or sense mPCR/RLB probes as described previously ). An inner primer was designed for each of the published sense and anti-sense primers with expected product size of around 100 bp. In total, 45 primer sets and 49 probes were assembled (some primer sets contained two probes). All primer sets were tested with each of the 42 reference strains using uniplex PCR (uPCR) and mPCR/RLB (Table 2) . uPCR and mPCR reactions. PCR amplifications were performed in a thermal cycler with HotStar Taq DNA polymerase (Qiagen). A 25 ml uPCR mixture was prepared follows: 2.5 ml 106 PCR buffer with a final MgCl 2 concentration of 1.5 mM, 0.2 mM deoxynucleoside triphosphates, 12.5 mM of each of the forward and reverse primers, 2 ml template DNA, 0.2 ml Qiagen Hotstar Taq polymerase (5 U ml 21 ) and molecular biology grade H 2 O (Eppendorf) was added to a total volume of 25 ml. Two mPCR mixes were prepared based on uPCR results for the 42 reference strains: the first contained 39 primer pairs (primer sets 1-18, 21-24 and 29-45, Table 2 ), which produced positive uPCR results for at least one strain tested, and the second contained six primer pairs (primer sets 19, 20, and 25-28, Table 2 ) that were uPCR negative for all the strains tested, but showed in silico matches with one or more SCCmec sequences in GenBank.
Each mPCR mix comprised 2 ml DNA template and 3 ml 106 PCR buffer with a final concentration of: 1.5 mM MgCl 2 (Qiagen), 0.2 mM dNTP, 1.5 U HotStar Taq DNA polymerase and 12.5 mM of each of the forward and reverse primers. Molecular biology grade H 2 O (Eppendorf) was added to a total volume of 30 ml. PCR was performed according to the Qiagen HotStar Taq polymerase kit instructions: 95 uC for 15 min; 35 cycles of 94 uC for 30 s, 55 uC for 30 s, 72 uC for 45 s, and 72 uC for 10 min. PCR products were stained with SYBR safe DNA gel stain and visualized in a 2 % agarose gel.
Reverse line blot (RLB) hybridization. The RLB hybridization assay was performed as described previously Cai et al., 2007) . Briefly, all probes, synthesized with a 59 amine modification at concentrations of 5-10 mM in 0.5 M NaHCO 3 (pH 8.4), were covalently linked to a Biodyne C hydrophilic nylon 6,6 (0.45 mm) membrane (PALL Gelman Laboratory), which was negatively activated by incubation in freshly prepared 16 % (w/v) 1ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC) (Sigma). The membrane was placed in a miniblotter (MN45, Immunetics) on a support cushion. A volume of 20 ml of PCR products was added to 150 ml 26 SSPE (Amresco) in 0.1 % SDS (Sigma), denatured at 100 uC for 10 min and cooled immediately on ice. Hybridization was conducted by adding 150 ml of the diluted denatured PCR products to alternate slots on the miniblotter, which was then incubated at 60 uC for 60 min. The membrane was washed twice in 26 SSPE buffer in 0.5 % SDS at 60 uC for 10 min, incubated in peroxidase-labelled streptavidin conjugate (Roche) at 42 uC for 60 min, then washed twice in 26 SSPE buffer in 0.5 % SDS at 42 uC for 10 min and twice in 26 SSPE buffer at room temperature for 5 min. For detection, the membrane was incubated in 15 ml chemiluminescence blotting substrate ECL detection reagent (Amersham, GE Healthcare) for 2 min, covered with transparent plastic sheet in a film cartridge and exposed with chemiluminescence film (Amersham Hyperfilm ECL, GE Healthcare) for 4 min. RLB results were regarded as positive when a hybridization dot signal was clearly visible.
Quality control of mPCR/RLB results. To ensure reproducibility of mPCR/RLB results, positive and negative controls were run on each membrane. The positive control was a mixture of DNA extracts from MRSA strains COL, BK2464, E822485, ANS46, DEN2988, PAH1, IP01M2046, RHH58, RPH74, B827549 and RPH2, which together contain all 43 probe targets; the negative control was master mix only, without DNA. Any signal produced by a test isolate that was similar to or stronger than the corresponding signal of the positive control was identified as positive. A signal produced by the negative control was assumed to be due to contamination and the assay was repeated. In practice, rare equivocal results would be resolved by uPCR for the relevant target, with sequencing of the amplicon, if required, as 'gold standard', but for the purpose of this study, all mPCR/RLB results were confirmed with uPCR.
SCCmec gene and staphylococcal whole-genome sequence analysis. Thirty-five SCCmec gene sequences published in NCBI GenBank, including 20 known SCCmec type (I-VI) and subtype sequences and 14 Staphylococcus aureus genome and 1 meticillinresistant S. epidermidis genome sequences were analysed as reference sequences and tested in silico using the mPCR/RLB assay. These sequences (with strain numbers; and DDBJ/EMBL/GenBank accession numbers) were as follows: (a) 18 SCCmec sequences: type I.1 SCCmec (NCTC10442; AB033763); type II.1 SCCmec (N315; D86934); type II.2 SCCmec (JCSC3063; AB127982); type II.B SCCmec (AR05; AJ810123); type II.3 (type IIE) SCCmec (AR13.1/ 3330.2; AJ810120); type II.4 SCCmec (RN7170; AB261975); type III.1 SCCmec (HU25; AF422696); type III.1 SCCmec and SCCmercury (85/ 2082; AB037671); type IV.1 SCCmec (CA05 [JCSC1968]; AB063172); type IV.2 SCCmec (JCSC1978 [8/6-3P] AB063173); type IV.3 SCCmec (81/108 [MR108]; AB096217); type IV.C SCCmec (2314; AY271717); type IV.4 SCCmec (JCSC4469; AB097677); type IV.E SCCmec (AR43/ 3330.1; AJ810121); type IV.g SCCmec (M03-68; DQ106887); type IV.h (PL72; AF411936); type V SCCmec (JCSC3624 [WIS]; AB121219); type VI SCCmec (HDE288; AF411935); and (b) 14 S. aureus genomes: COL (CP000046), JH1 (CP000736), JH9 (CP000703), MRSA252 (BX571856), MW2 (BA000033), Mu3 (AP009324), Mu50 (BA000017), N315 (BA000018), USA300 (CP000255), USA300_TCH1516 (CP000730), RF122 (AJ938182), MSSA476 (BX571857), NCTC8325 (CP000253), Newman (AP009351).
In addition, the mPCR/RLB system was tested in silico against wholegenome and partial SCCmec sequences of seven non-MRSA strains: five meticillin-susceptible S. aureus (MSSA) [AJ938182, BX571857, CP000253, AP009351, AM983545 (SSCmec type II)], plus one meticillin-resistant coagulase-negative Staphylococcus [S. epidermidis CP000029 (SCCmec type II)] and Staphylococcus pseudintermedius [AM904732 (SCCmec type III)].
GenBank SCCmec sequence searches and alignments and design of primers and probes were conducted using BioManager (Sydney Bioinformatics, https://www.angis.org.au/) and Sigma (http:// www.sigma-genosys.com/calc/DNACalc.asp) browsers. Results of BLASTN alignments of designed probe sequences with all currently available SCCmec types (I-VI) and subtype sequences (35 GenBank reference sequences) including whole-genome and partial SCCmec sequences of non-MRSA staphylococci were applied for in silico prediction of RLB hybridization patterns. The uPCR and mPCR/RLB results were recorded as binary data, exported into BioNumerics software (version 4.6, Applied Maths). Dendrograms were generated using the categorical coefficient and clustering by UPGMA algorithm.
Statistical analysis. The discriminatory power was estimated by calculating Simpson's index of diversity (Hunter & Gaston, 1988 ) and the 95 % confidence intervals (CI) were determined as described previously (Grundmann et al., 2001) . 59 end) ; n, non-biotin-labelled primers; p, C 6 -amine-labelled-probes (at the 59 end). All primers labelled with biotin were based on previously published sequences (Kondo et al., 2007) . Non-biotin-labelled primers and probes were designed for this study. 
RESULTS AND DISCUSSION
SCCmec type characteristics of the reference strains in mPCR/RLB assays
All 42 reference strains were tested by uPCR and mPCR using all 45 primer sets ( Table 2 ). The majority produced amplicons of the expected size in the uPCR, but six (primer sets 19, 20, 25-28) gave negative results. The two groups of primers (the 39 that generated and six that did not generate amplicon signals in the uPCR) were further studied in two separate mPCRs. Fig. 1 shows mPCR/RLB findings using the 39 primers that had given positive results in uPCR. As the other six primer sets did not produce signals with the 42 test isolates, they were removed from the membrane, to save space, and labelled onto a second membrane for use in subsequent studies.
The uPCR results were consistent with those of mPCR/ RLB, with the following exceptions: primers bc1Sn and bcb amplified SCCmec from strains FH53, SJOG30, RHH58, B827549 and SN39 in the uPCR but produced no signal in mPCR/RLB with probe ccrB1Sp (Fig. 1, lanes 1, 34, 35, 39 and 40, respectively), presumably due to a major sequence variation in the probe region. There were minor differences in intensities of signal dots but, since this is a binary typing system, clear signals similar to or stronger than positive controls on the membrane were regarded as positive. This approach was validated internally by the use of paired (sense/antisense) probes and by comparison of the signals within and between the probes. In our experience, a weak signal reflects minor sequence variation (1-2 bp) and an absent signal represents at least a 2 bp sequence change in the corresponding probe region, as suggested previously (Wang et al., 2008) . However, discordant signals between Fig. 1 . RLB patterns of 41 reference strains of MRSA. Lane P, artificial positive control, Lane N, negative control (PCR master mix) Lanes 1-42: 1, FH53; 2; COL; 3, BK2464; 4, E822485; 5, RPAH18; 6, RPAH15; 7, HDG2; 8, 14176-5710; 9, RDH81; 10, AH1; 11, AH13; 12, HU25; 13, K704540; 14, K711532; 15, ANS46; 16, PC8; 17, FH43; 18, RPH85; 19, RHH10; 20, B8-10; 21, PAH58; 22, E804531; 23, CH97; 24, RBH98; 26, IP01M1081; 27, MW2; 28, CH16; 29, CH69; 30, DEN2988; 31, F829549; 32, PAH1, 33, IP01M2046; 34, SJOG30; 35, RHH58; 36, IMVS67; 37, RPH74; 38, J710566; 39, B827549; 40, SN39; 41, RPH2; 42, C801535. [Note: strain 25 (13792-4492) was not included; it gave results identical to those of strain 24 (RBH98).]
L. Cai and others probe pairs (one positive -weak or strong -and one negative) can occur but are rare. uPCR and sometimes sequencing, using the same primers as used for that target in the mPCR, can be used to determine whether the discrepancy is due to a modified target (amplicon present) or a non-specific cross-reaction (amplicon absent).
In silico comparison of probe sequences with SCCmec gene sequences
The potential sensitivity of the probes designed in the study was assessed in an in silico experiment. The GenBank sequences of 14 S. aureus whole-genome sequences, 14 partial SCCmec sequences and seven non-MRSA genome and SCCmec sequences were downloaded and compared with probe sequences from this study using BLASTN pairwise alignments. The results are expressed as virtual RLB profiles in Fig. 2 (Kondo et al., 2007) . The SCCmec type patterns identified by RLB in our 42 reference strains were generally consistent with those extrapolated from MRSA SCCmec gene sequences in the public domain. For example, the majority of SCCmec type IV strains (Fig.  1, lanes 15-26) had SCCmec profiles indistinguishable from that of the genome sequence ID 27 (Fig. 2, lane 27,  CP000255 ). Altogether 15 of 42 strains (35 %) had the same RLB patterns as those of corresponding GenBank sequences. However, there was some heterogeneity in the RLB patterns of other reference strains compared with GenBank sequences of the same SCCmec types. For example, RLB patterns of reference strains of SCCmec type III differed from the published MRSA SCCmec type III subtype 1 sequence (Fig. 2, lane 8, AB037671 ). This heterogeneity suggests the existence of distinct SCCmec type III subtypes (Fig. 2) .
Theoretical RLB profiles of seven non-MRSA genome sequences are shown in Fig. 2 . Four of five MSSA demonstrated no matches between probes and genomes, but one MSSA, and both meticillin-resistant coagulasenegative Staphylococcus strains, contained some SCCmec elements, as shown by matching of variable numbers of probes with their genomic sequences. These results are consistent with previous findings of SCCmec elements in MSSA and coagulase-negative staphylococci (Mombach Pinheiro Machado et al., 2007; Hanssen & Sollid, 2007) . It has been postulated that SCCmec elements can be transferred from coagulase-negative staphylococci to S. aureus (Shore et al., 2008) . Our results suggest that our mPCR/RLB typing system could also be extended to study of the distribution of SCCmec elements in other staphylococci.
Discrimination of SCCmec genotypes by mPCR/ RLB
The mPCR/RLB SCCmec typing system developed in this study was based on an mPCR typing scheme described by Kondo et al. (2007) using ccr and mec gene complexes types with further discrimination based on differences in junkyard region 1 and the presence or absence of integrated transposons and plasmids. Another recently developed SCCmec typing system used minimal subsets of targets on ccr and mec gene complexes and three junkyard regions to provide maximal discriminatory capacity (Stephens et al., 2007) . The rationales for these two strategies are different: the former is based on known SCCmec variants, whereas the latter maximizes discrimination, by recognizing single nucleotide polymorphisms (SNPs) and is not limited to known SCCmec types. Our system was designed as an extension of the Kondo scheme, to discriminate major known SCCmec types and subtypes rapidly. However, it can be easily modified to accommodate probes for newly identified SCCmec elements.
The set of 42 well-characterized MRSA reference strains included isolates representing 5 SCCmec types, 9 clonal clusters, 22 spa types, 7 nuc types, 9 femA types, 14 toxin types and 15 MLST types (Cai et al., 2007) . The mPCR/ RLB assay classified reference strains into 26 SCCmec subtypes, including one of SCCmec type I (1 strain), two of SCCmec II (2 strains), eight of SCCmec III (11 strains), eight of SCCmec IV (21 strains) and three of SCCmec V (3 strains). MRSA SCCmec type IV and its variants have increased in importance in recent years because they have been identified in virulent community-acquired strains (Deurenberg & Stobberingh, 2008) . Four of the previously unclassified strains demonstrated unique RLB patterns resembling SCCmec types IV and V (Fig. 3) .
Different sequence-based typing methods targeting different types of gene may not be directly comparable but they are often proposed as alternatives to pulsed-field gel electrophoresis for strain typing. The mPCR/RLB SCCmec typing method showed similar discriminatory power to that of MLST and spa typing in this small but diverse strain collection, as indicated by Simpson indices of diversity of 0.916 (CI 88. 1, AB033763 (I.1); 2, D86934 (II.1); 3, AB127982 (II.2); 4, AJ810123 (IIB); 5, AJ810120 (II.3); 6, AB261975 (II.4); 7, AF422696 (III.1); 8, AB037671 (III.1); 9, AB063172 (IV.1); 10, AB063173 (IV.2); 11, AB096217 (IV.3); 12, AY271717 (IVC); 13, AB097677 (IV.4); 14, AJ810121 (IVE); 15, DQ106887 (IVg); 16, AF411936 (IVh); 17, AB121219 (V); 18, AF411935 (VI); 19, CP000046 (I); 20, CP000736 (II); 21, CP000703 (II); 22, BX571856 (II); 23, BA000033 (II); 24, AP009324 (IIa); 25, BA000017 (II); 26, BA000018 (IV); 27, CP000255 (IV); 28, CP000730. Lanes 29-33 (5 MSSA sequences): 29, AJ938182; 30, BX571857; 31, CP000253; 32, AP009351; 33, AM983545 (IID). Lanes 34-35: 34, CP000029 (II) -meticillin-resistant S. epidermidis genome; 35, AM904732 (II/III) -meticillin-resistant S. pseudintermedius. The black squares represent perfect matches of probe sequences with the GenBank SCCmec sequences; the white squares represent probes for which there was no matching GenBank sequence at the time of study (July 2008).
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SCCmec types/subtypes among clinical MRSA isolates with increased accuracy and study relationships between them. Reference strain FH53 (lane 1, Fig. 2) was previously reported to be SCCmec type I (Cai et al., 2007) . However, it appears to be similar to SCCmec IV reference and clinical strains as well as to the published SCCmec type IV sequence Rapid SCCmec typing of MRSA ( Fig. 3) . There was also one genetic marker difference (probe bc2Sp) for strain MW2 between the mPCR/RLB assay and in silico results which could be attributed to the polymorphism of the binding site.
Advantages of the mPCR/RLB approach
The SCCmec gene typing initially proposed by Kondo et al. (2007) involves several mPCRs that produce amplicons of significant size (up to 15 kb) and requires gel-based detection. These features reduce the relevance of the typing scheme for infection-control-based interventions and tracking of introduction or transmission of different SCCmec types/subtypes. In contrast, the application of mPCR/RLB to the SCCmec typing described here enables the simultaneous screening of up to 43 samples using two mPCRs with a turnaround time (including culturing of isolates, DNA extraction, mPCR setup and running, and RLB hybridization) of about two working days. The preparation of the RLB membrane takes less than 2 h, and it can be reused at least 20 times based on our experience. The consumables cost is~AU$8 per isolate. The results of mPCR/RLB can be represented as binary data, which are easily transferred and shared between diagnostic and public health laboratories, making the SCCmec typing easier to harmonize and suitable for rapid epidemiological studies of large numbers of isolates.
In conclusion, this SSCmec typing system improves our capacity to monitor molecular evolution and spread of MRSA and contributes to the development of effective strategies to control its dissemination. The application of the mPCR/RLB hybridization assay to MRSA SCCmec typing enhances the specificity, discriminatory power and throughput of the typing procedure. The sequence detection of up to 43 mPCR products in a single hybridization assay can transform MRSA SCCmec typing from epidemiological library typing into a tool for nearreal-time infection control surveillance and MRSA hospital transmission tracking.
